vs
Side-by-side financial comparison of GLADSTONE COMMERCIAL CORP (GOOD) and Valneva SE (VALN). Click either name above to swap in a different company.
GLADSTONE COMMERCIAL CORP is the larger business by last-quarter revenue ($41.9M vs $36.2M, roughly 1.2× Valneva SE). GLADSTONE COMMERCIAL CORP runs the higher net margin — 16.6% vs -54.1%, a 70.7% gap on every dollar of revenue.
Gladstone Commercial Corp is a publicly traded US real estate investment trust focused on acquiring, owning, and operating diversified industrial and commercial properties. It offers long-term net lease agreements to tenants across manufacturing, logistics, healthcare and professional services sectors, mainly serving small to mid-sized business clients.
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States.
GOOD vs VALN — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2023
| Metric | | |
|---|---|---|
| Revenue | $41.9M | $36.2M |
| Net Profit | $7.0M | $-19.6M |
| Gross Margin | — | 38.9% |
| Operating Margin | 160.2% | -49.5% |
| Net Margin | 16.6% | -54.1% |
| Revenue YoY | -3.6% | — |
| Net Profit YoY | 29.5% | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $41.9M | — | ||
| Q4 25 | $43.5M | — | ||
| Q3 25 | $40.8M | — | ||
| Q2 25 | $39.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.4M | — | ||
| Q3 24 | $39.2M | — | ||
| Q2 24 | $37.1M | — |
| Q1 26 | $7.0M | — | ||
| Q4 25 | $5.4M | — | ||
| Q3 25 | $4.1M | — | ||
| Q2 25 | $4.6M | — | ||
| Q1 25 | $5.1M | — | ||
| Q4 24 | $7.2M | — | ||
| Q3 24 | $11.7M | — | ||
| Q2 24 | $1.6M | — |
| Q1 26 | 160.2% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 16.6% | — | ||
| Q4 25 | 12.4% | — | ||
| Q3 25 | 10.1% | — | ||
| Q2 25 | 11.7% | — | ||
| Q1 25 | 13.7% | — | ||
| Q4 24 | 19.2% | — | ||
| Q3 24 | 29.8% | — | ||
| Q2 24 | 4.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | $0.05 | — | ||
| Q3 25 | $0.02 | — | ||
| Q2 25 | $0.03 | — | ||
| Q1 25 | $0.04 | — | ||
| Q4 24 | $0.10 | — | ||
| Q3 24 | $0.20 | — | ||
| Q2 24 | $-0.04 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $221.2M |
| Total Assets | $1.2B | $637.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $10.8M | — | ||
| Q3 25 | $18.4M | — | ||
| Q2 25 | $11.7M | — | ||
| Q1 25 | $10.4M | — | ||
| Q4 24 | $11.0M | — | ||
| Q3 24 | $10.5M | — | ||
| Q2 24 | $10.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | $843.5M | — | ||
| Q3 25 | $843.3M | — | ||
| Q2 25 | $794.4M | — | ||
| Q1 25 | $740.7M | — | ||
| Q4 24 | $693.4M | — | ||
| Q3 24 | $692.6M | — | ||
| Q2 24 | $722.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | $171.8M | — | ||
| Q3 25 | $184.8M | — | ||
| Q2 25 | $177.2M | — | ||
| Q1 25 | $183.2M | — | ||
| Q4 24 | $171.2M | — | ||
| Q3 24 | $168.9M | — | ||
| Q2 24 | $145.7M | — |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — |
| Q1 26 | — | — | ||
| Q4 25 | 4.91× | — | ||
| Q3 25 | 4.56× | — | ||
| Q2 25 | 4.48× | — | ||
| Q1 25 | 4.04× | — | ||
| Q4 24 | 4.05× | — | ||
| Q3 24 | 4.10× | — | ||
| Q2 24 | 4.96× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-26.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $88.2M | — | ||
| Q3 25 | $18.9M | — | ||
| Q2 25 | $35.8M | — | ||
| Q1 25 | $17.7M | — | ||
| Q4 24 | $57.0M | — | ||
| Q3 24 | $5.5M | — | ||
| Q2 24 | $13.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | 16.38× | — | ||
| Q3 25 | 4.57× | — | ||
| Q2 25 | 7.74× | — | ||
| Q1 25 | 3.44× | — | ||
| Q4 24 | 7.93× | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 8.44× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
